Tg Therapeutics (TGTX) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $158.8 million.
- Tg Therapeutics' Shares Outstanding rose 182.37% to $158.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $158.8 million, marking a year-over-year increase of 182.37%. This contributed to the annual value of $156.2 million for FY2024, which is 312.85% up from last year.
- Latest data reveals that Tg Therapeutics reported Shares Outstanding of $158.8 million as of Q3 2025, which was up 182.37% from $158.8 million recorded in Q2 2025.
- Over the past 5 years, Tg Therapeutics' Shares Outstanding peaked at $158.8 million during Q2 2025, and registered a low of $141.5 million during Q1 2021.
- Moreover, its 5-year median value for Shares Outstanding was $151.0 million (2023), whereas its average is $150.2 million.
- Its Shares Outstanding has fluctuated over the past 5 years, first surged by 2841.09% in 2021, then soared by 162.68% in 2022.
- Tg Therapeutics' Shares Outstanding (Quarter) stood at $143.3 million in 2021, then rose by 2.19% to $146.4 million in 2022, then grew by 3.44% to $151.5 million in 2023, then rose by 3.13% to $156.2 million in 2024, then increased by 1.63% to $158.8 million in 2025.
- Its Shares Outstanding was $158.8 million in Q3 2025, compared to $158.8 million in Q2 2025 and $158.7 million in Q1 2025.